Abstract: A surface treatment formulation configured to inhibit scaling or climbing of a surface is provided. The surface treatment formulation may include a base binding material configured to adhere to the surface and a filler material embedded in the base binding material. The filler material may include a dry lubricant having a layered lamellar structure or low inter filler interaction. Furthermore, the surface treatment formulation may be configured to be activated in order to expose the filler material thereby causing formation of a slippery surface to inhibit the scaling or climbing of the surface.

Abstract: A surface treatment formulation configured to inhibit scaling or climbing of a surface is provided. The surface treatment formulation may include a base binding material configured to adhere to the surface and a filler material embedded in the base binding material. The filler material may include a dry lubricant having a layered lamellar structure or low inter filler interaction. Furthermore, the surface treatment formulation may be configured to be activated in order to expose the filler material thereby causing formation of a slippery surface to inhibit the scaling or climbing of the surface.

Abstract: A method of preparing a high capacity nanocomposite cathode of FeF3 in carbon pores may include preparing a nanoporous carbon precursor, employing electrochemistry or solution chemistry deposition to deposit Fe particles in the carbon pores, reacting nano Fe with liquid hydrofluoric acid to form nano FeF3 in carbon, and milling to achieve a desired particle size.

Abstract: A biomaterial implant may include a collagen membrane. The biomaterial implant may further include a plurality of nanoparticles embedded in the collagen membrane. Furthermore, at least one nanoparticle of the plurality of nanoparticles may include a polymer shell and a bio-active therapeutic agent encapsulated by the polymer shell.

Abstract: A therapeutic agent release system may be provided. The therapeutic agent release system may include a plurality of polymer shells having a diameter of about 50-200 nanometers. The therapeutic agent release system may further include a bio-active therapeutic agent encapsulated by each of the polymer shells and being configured to heal an injury and increase a wound electric signal of the injury thereby increasing a healing rate of the injury. Each of the polymer shells may have a degradation profile configured to control a release of the bio-active therapeutic agent through the polymer shell to the injury over a predetermined period of time.

Abstract: A method of preparing a high capacity nanocomposite cathode of FeF3 in carbon pores may include preparing a nanoporous carbon precursor, employing electrochemistry or solution chemistry deposition to deposit Fe particles in the carbon pores, reacting nano Fe with liquid hydrofluoric acid to form nano FeF3 in carbon, and milling to achieve a desired particle size.

Abstract: A method of preparing a high capacity nanocomposite cathode of FeF3 in carbon pores may include preparing a nanoporous carbon precursor, employing electrochemistry or solution chemistry deposition to deposit Fe particles in the carbon pores, reacting nano Fe with liquid hydrofluoric acid to form nano FeF3 in carbon, and milling to achieve a desired particle size.

Abstract: A thin film electrode is fabricated from a non-metallic, non-conductive porous support structure having pores with micrometer-range diameters. The support may include a polymer film. A first surface of the support is metalized, and the pores are partially metallized to create metal tubes having a thickness within a range of 50 to 150 nanometers, in contact with the metal layer. An active material is disposed within metalized portions of the pores. An electrolyte is disposed within non-metalized portions of the pores. Active materials may be selected to create an anode and a cathode. Non-metalized surfaces of the anode and cathode may be contacted to one another to form a battery cell, with the non-metalized electrolyte-containing portions of the anode facing the electrolyte-containing portions of the cathode pores. A battery cell may be fabricated as, for example, a nickel-zinc battery cell.

Abstract: A thin film electrode is fabricated from a non-metallic, non-conductive porous support structure having pores with micrometer-range diameters. The support may include a polymer film. A first surface of the support is metalized, and the pores are partially metallized to create metal tubes having a thickness within a range of 50 to 150 nanometers, in contact with the metal layer. An active material is disposed within metalized portions of the pores. An electrolyte is disposed within non-metalized portions of the pores. Active materials may be selected to create an anode and a cathode. Non-metalized surfaces of the anode and cathode may be contacted to one another to form a battery cell, with the non-metalized electrolyte-containing portions of the anode facing the electrolyte-containing portions of the cathode pores. A battery cell may be fabricated as, for example, a nickel-zinc battery cell.

Abstract: Thin-film electrodes and battery cells, and methods of fabrication. A thin film electrode may be fabricated from a non-metallic, non-conductive porous support structure having pores with micrometer-range diameters. The support may include a polymer film. A first surface of the support is metalized, and the pores are partially metallized to create metal tubes having a thickness within a range of 50 to 150 nanometers, in contact with the metal layer. An active material is disposed within metalized portions of the pores. An electrolyte is disposed within non-metalized portions of the pores. Active materials may be selected to create an anode and a cathode. Non-metalized surfaces of the anode and cathode may be contacted to one another to form a battery cell, with the non-metalized electrolyte-containing portions of the anode facing the electrolyte-containing portions of the cathode pores. A battery cell may be fabricated as, for example, a nickel-zinc battery cell.

Abstract: A method of preparing a high capacity nanocomposite cathode of FeF3 in carbon pores may include preparing a nanoporous carbon precursor, employing electrochemistry or solution chemistry deposition to deposit Fe particles in the carbon pores, reacting nano Fe with liquid hydrofluoric acid to form nano FeF3 in carbon, and milling to achieve a desired particle size.

Abstract: Thin-film electrodes and battery cells, and methods of fabrication. A thin film electrode may be fabricated from a non-metallic, non-conductive porous support structure having pores with micrometer-range diameters. The support may include a polymer film. A first surface of the support is metalized, and the pores are partially metallized to create metal tubes having a thickness within a range of 50 to 150 nanometers, in contact with the metal layer. An active material is disposed within metalized portions of the pores. An electrolyte is disposed within non-metalized portions of the pores. Active materials may be selected to create an anode and a cathode. Non-metalized surfaces of the anode and cathode may be contacted to one another to form a battery cell, with the non-metalized electrolyte-containing portions of the anode facing the electrolyte-containing portions of the cathode pores. A battery cell may be fabricated as, for example, a nickel-zinc battery cell.

Abstract: A drug delivery system, product and method which effectuates delivery of appropriate amounts of a pharmaceutically active agent only upon stimulus of a physiological agent released during a disease event are described. A polymer that can bind to a specific biological stimulus and respond with a specific response is included. The response may be release of a pharmaceutical agent, an optical signal or a change in physical properties of the polymer. The design of associative polymers that are held together using temporary bonds which will dissolve, break apart or swell in the presence of the specific stimulus are described. One embodiment includes a reversible response to a biological stimulus.